s BM The role of radioactive iodine in the treatment of advanced differentiated thyriod carcinoma. // Clin Endocrinol (Oxf); 1997 47 (6) :713-20
Petrich T., Borner A.R., Weckesser E., et al. Follow-up of differentiated thyroid cancer patients using rhTSH - preliminary results. // Nuklearmedizin; 2001 40 (1) :7-14
Pichon MF, Basuyau JP, Gory-Delabaere G., et al. Standards, options and recommendations for blood tumor markers in thyroid cancers. // Bull Cancer; 2001 88 (8) :775-92
Pineda J.D., Lee T., Ain K., et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan [see comments]. // J Clin Endocrinol Metab; 1995 80 (5) :1488-92
Ramanna L., Waxman A.D., Brachman M.B., et al. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyriod cancer patients. // Clin Nuck Med; 1985 10 (11) :791-5
Reynolds J.C. How much uptake is enough to treat? Are post therapy scans worhwhile? // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.81
Reynolds JC, Comparison of I-131 absorbed radiation doses in children and adalts: a tool for estimating therapeutic I-131 doses in children. // In: NIH proceedings of a workshop, September 10-11, 1992, p. 125-133. p> Reynolds J.C., Robbins J. The changing role of radioiodine in the management of differentiated thyriod cancer. // Semin Nucl Med; 1997 27 (2) :152-64
Ronga G., Fiorentino A., Paserio E., et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in post-surgical follow-up of differentiated thyriod carcinoma. // J Nucl Med; 1990 31 (11) :1766-71
Rosler H., Birrer A., ​​Luscher D., Kinser J. Long-term course in differentiated thyroid gland carcinoma. // Schweiz Med Wochenschr; 1992 122 (48) :1843-57
Salvatori M., Rufini V., Garganese MC, Di Giuda D. Radioiodine therapy in differentiated thyroid carcinoma. // Rays; 2000 25 (2) :221-38
Samaan NA, Schultz PN, Haynie TP, Ordonez NG Pulmonary metastases of differentiated thyriod carcinoma: treatment results in 101 patients. // J Clin Endocrinol Metab; 1985 60 (2) :376-80
Samaan, N.A., Schultz P.N. Hickey R.C. et al. The result of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective rewiew of 1599 patients. // J Clin Endocrin Metabol; 1992 75 (3) :714-720
Samuel A.M., Rajashekharrao B., Shah D.H. Pulmonary metastases in children and adolescents with well-differentiated thyriod cancer.// J Nucl Med; 1998 39 (9) :1531-6
Sanders L.E., Cady B. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment. // Arch. Surg. - 1998.-Vol.133. № 4.-P.419-425. p> Santora J., Nemec J., Kubinyi J. Therapy of thyroid carcinoma using radioiodine. // Cas Lek Cesk; 2001 140 (7) :217-9
Sarkar S.D., Afriyie M.O., Palestro C.J. Recombinant human thyroid-stimulating h...
